{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:38:07Z","timestamp":1777480687342,"version":"3.51.4"},"reference-count":35,"publisher":"Media Sphere Publishing House","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>According to the literature, a number of anti-epileptic drugs (AEDs) have an ototoxic effect. The mechanism of hearing dysfunction due to the use of AEDs is not well known. The main clinical manifestations of the cochleotoxic effect of the drugs are: tinnitus, sensorineural hearing loss, impaired pitch perception, hyperacusis. These disorders can be reversible and irreversible. Attending physicians should be careful when prescribing AEDs to patients who have had hearing impairment before, as well as diagnose hearing loss in a timely manner with subsequent correction of anti-epileptic therapy.<\/jats:p>","DOI":"10.17116\/jnevro202412412114","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T08:09:17Z","timestamp":1735373357000},"page":"14","source":"Crossref","is-referenced-by-count":1,"title":["Ototoxicity caused by anti-epileptic drugs"],"prefix":"10.17116","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0804-7076","authenticated-orcid":false,"given":"S.G.","family":"Burd","sequence":"first","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]},{"name":"Pirogov Russian National Research Medical University (Pirogov University)","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8712-4775","authenticated-orcid":false,"given":"A.V.","family":"Lebedeva","sequence":"additional","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]},{"name":"Pirogov Russian National Research Medical University (Pirogov University)","place":["Moscow, Russia"]},{"name":"Research Institute of Health Care Organization and Medical Management","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-1797","authenticated-orcid":false,"given":"Yu.V.","family":"Rubleva","sequence":"additional","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9066-7907","authenticated-orcid":false,"given":"A.P.","family":"Efimenko","sequence":"additional","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-7662","authenticated-orcid":false,"given":"N.V.","family":"Pantina","sequence":"additional","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5393-899X","authenticated-orcid":false,"given":"A.V.","family":"Yurchenko","sequence":"additional","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5229-6558","authenticated-orcid":false,"given":"M.A.","family":"Bogomazova","sequence":"additional","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8496-7475","authenticated-orcid":false,"given":"I.I.","family":"Kovaleva","sequence":"additional","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3015-1881","authenticated-orcid":false,"given":"G.A.","family":"Alekseeva","sequence":"additional","affiliation":[{"name":"Federal Center of Brain Research and Neurotechnologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202412412114-1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1372420"},{"key":"key-10.17116\/jnevro202412412114-2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03552-X"},{"key":"key-10.17116\/jnevro202412412114-3","doi-asserted-by":"publisher","DOI":"10.34883\/PI.2022.12.2.021"},{"key":"key-10.17116\/jnevro202412412114-4","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-017-0626-4"},{"key":"key-10.17116\/jnevro202412412114-5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2022.12.001"},{"key":"key-10.17116\/jnevro202412412114-6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.40.12.1896"},{"key":"key-10.17116\/jnevro202412412114-7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.42.1153"},{"key":"key-10.17116\/jnevro202412412114-8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2006.12.011"},{"key":"key-10.17116\/jnevro202412412114-9","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2014.0671"},{"key":"key-10.17116\/jnevro202412412114-10","unstructured":"Stoorvogel M.S, Verhagen CVM, Verhagen WIM. Valproic Acid Induced Sensorineural Hearing Loss; a Case Report of Partially Reversible Hearing Loss In a Patient Treated With Valproic Acid. J Neurol Neuro Toxicol. 2018;2(1):001-003"},{"key":"key-10.17116\/jnevro202412412114-11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000082396.01692.53"},{"key":"key-10.17116\/jnevro202412412114-12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.09.004"},{"key":"key-10.17116\/jnevro202412412114-13","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.2.225"},{"key":"key-10.17116\/jnevro202412412114-14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(90)90283-4"},{"key":"key-10.17116\/jnevro202412412114-15","unstructured":"Tateno A, Morisawa K, Sawai K, Koya N. Three cases of partial epilepsy accompanied by hearing disorder during CBZ medication. Shonika Rinsho 1993;46:323-326"},{"key":"key-10.17116\/jnevro202412412114-16","doi-asserted-by":"publisher","DOI":"10.1121\/1.411437"},{"key":"key-10.17116\/jnevro202412412114-17","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200007000-00010"},{"key":"key-10.17116\/jnevro202412412114-18","doi-asserted-by":"publisher","DOI":"10.1177\/088307380401900611"},{"key":"key-10.17116\/jnevro202412412114-19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1819.2001.00883.x"},{"key":"key-10.17116\/jnevro202412412114-20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2006.01.011"},{"key":"key-10.17116\/jnevro202412412114-21","unstructured":"Onodera M, Ogino T. A case report on auditory disturbance secondary to carbamazepine. Nippon Jibiinkouka Gakkai Kaihou 1994;97:562"},{"key":"key-10.17116\/jnevro202412412114-22","unstructured":"Mabuchi K, Hayashi S, Nitta E, et al. Auditory disturbance induced by carbamazepine administration in a patient with secondary generalized seizure. Rinsho Shinkeigaku= Clinical Neurology. 1995;35(5):553-555"},{"key":"key-10.17116\/jnevro202412412114-23","unstructured":"Senzyo M. A case of psychogenic reaction, whose tone was flattened by carbamazepine. Seisin Igaku. 1995;37:649-651"},{"key":"key-10.17116\/jnevro202412412114-24","unstructured":"Nihei K, Naito Y. Two cases of absolute pitch perception caused by carbamazepine. J Jpn Epil Soc. 1997;15:68-69"},{"key":"key-10.17116\/jnevro202412412114-25","unstructured":"Yamamoto M, Wada K, Sakai K, Kugoh T. Auditory disturbance induced by carbamazepine. Epilepsia. 1997;38:132"},{"key":"key-10.17116\/jnevro202412412114-26","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.37.774"},{"key":"key-10.17116\/jnevro202412412114-27","unstructured":"Emori K. A case of complex partial seizure showing reversible semitone lowing during the elevation of CBZ blood concentration. J Jpn Epil Soc. 2000;18:71"},{"key":"key-10.17116\/jnevro202412412114-28","unstructured":"Watanabe T, Minagawa K, Nihira H, Ito N. Two cases of auditory disturbance due to carbamazepine. Tenkan Nituite. 2000;20:39-44"},{"key":"key-10.17116\/jnevro202412412114-29","unstructured":"Tateno A, Omura I. Two cases of auditory disturbance caused by carbamazepine. No to Hattatsu= Brain and Developmen. 2000;32(5):420-4233"},{"key":"key-10.17116\/jnevro202412412114-30","doi-asserted-by":"publisher","DOI":"10.2169\/naika.94.759"},{"key":"key-10.17116\/jnevro202412412114-31","doi-asserted-by":"publisher","DOI":"10.1016\/s0387-7604(02)00155-9"},{"key":"key-10.17116\/jnevro202412412114-32","doi-asserted-by":"publisher","DOI":"10.1016\/s0967-5868(03)00068-7"},{"key":"key-10.17116\/jnevro202412412114-33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2005.05.015"},{"key":"key-10.17116\/jnevro202412412114-34","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2012.11.010"},{"key":"key-10.17116\/jnevro202412412114-35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebcr.2018.12.001"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:04:00Z","timestamp":1745384640000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2024\/12\/1199772982024121014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,28]]}},"alternative-id":["10.17116\/jnevro202412412114"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202412412114","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}